Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

10x Genomics, Inc. Class A Common Stock | TXG

Daily Technical Analysis of 10x Genomics, Inc. Class A Common Stock

10x Genomics hasn't moved too much today but is slightly down, it has lost -0.22% since yesterday.

Currently TXG isn't at a clear support/resistance line that seems tradable. 10x Genomics hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. TXG might find some support at the 41.85 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-03-17

Analyst Ratings for 10x Genomics By Price Target And Rating

The balance of viewpoints by the analysts is positive. The current Analysts Sentiment Score is 70.99. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-02-16 Stifel Nicolaus lowered their price target by -7.35% to $63.00. On 2024-01-25 Barclays increased their price target by 22.22% to $55.00. Guggenheim initiated a rating of Buy on 2023-12-14 and they set their price target at $60.00.On 2023-12-13 Wolfe Research started covering 10x Genomics with a rating of Outperform and added a price target of $55.00. Bank of America announced an upgrade on 2023-12-12 from Underperform to Neutral and moved up their price target to $54.00 which is a 50% increase. Canaccord Genuity Group reiterated a rating of Buy on 2023-09-19 and provided a price target of $70.00. On 2023-08-07 Morgan Stanley reiterated their rating of Overweight and added a price target of $65.00. On 2023-08-04 Citigroup increased their price target by 15.38% to $75.00. Stephens initiated a rating of Overweight on 2023-03-30 and they set their price target at $65.00.Cowen gave a boost to their price target and moved to $57.00 from $52.00 on 2023-02-16.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
TXG70.9983.3065.57-6.89

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-03-28)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
TXG0.000.00

Short interest for 10x Genomics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
TXG8%6.48227.231.0866700000

Social Sentiment for 10x Genomics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
TXG

Companies with the highest correlation to 10x Genomics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
ADPT | Adaptive Biotechnologies 1.170.7811.35-10.03-34.18-44.56-65.0524-67.78-68.18-89.95-60811.010.0001507.83993
HCAT | Health Catalyst, Inc Comm1.117.685.88-18.95-41.34-20.45-50.6122-9.94-14.48-15.38-20146.32-1156.72003.38022
TWST | Twist Bioscience Corporat1.09-2.388.43-10.82-7.3885.46140.612026.2150.7192.05-7098.72-10006.210023.3961
GH | Guardant Health, Inc. Com1.094.388.580.78-18.69-31.28-15.6232-97.83-54.77-28.90-47047.790.00005.7115
PACB | Pacific Biosciences of Ca1.05-41.98-50.60-54.81-76.09-79.39-85.0627-93.79-62.33-71.02-58610.720.000014.0556

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-